Compound of brain protein hydrolyzate and maleic acid and method for preparing same

A technology of cerebroprotein hydrolyzate and maleic acid, which is applied in the field of medicine, can solve problems such as unstable chemical properties of cerebroprotein hydrolyzate, inconvenient drug production, storage and transportation, and unsatisfactory brain targeting, so as to ensure clinical drug use Safety, improve the ability to withstand hypoxia at normal pressure, and prolong the effect of entering the incubation period

CN101732695AActive Publication Date: 2010-06-16BEIJING SIHUAN PHARMA +1
5 Cites 3 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2010-06-16

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides compound of brain protein hydrolyzate and maleic acid and a method for preparing the same and also provides a method for preparing dispersible tablets of the medicinal compound of brain protein hydrolyzate and maleic acid, belonging to the technical field of the medicament. The medicinal compound of brain protein hydrolyzate and maleic acid is the peptidergic neural nutritional medicament specially used for the brain and can act on the central nervous system in various ways to adjust and improve the neuronal differentiation. The medicinal compound of brain protein hydrolyzate and maleic acid can promote the synthesis of the brain protein through a blood-brain barrier, has the efficacy of preventing hypoxia, improving the brain energy metabolism and providing neurotransmitter, peptide hormones and coenzyme precursors and can be used for preparing the medicament for improving insomnia, headache, memory loss, irritability and other symptoms, promoting the rehabilitation of acute cerebral infarction and acute brain injury and treating brain dysfunction.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition made of cerebroprotein hydrolyzate and maleic acid, a preparation method thereof, and an application of the composition in preparing medicine for treating brain dysfunction. Background technique

[0002] Brain dysfunction includes brain tissue ischemia and hypoxia injury, acute and chronic cerebrovascular disease, brain trauma, various toxic encephalopathy and other causes of cranial nerve dysfunction and memory loss, congenital brain hypoplasia, children's mental retardation , Alzheimer's disease, etc. Brain tissue is very sensitive to ischemia and hypoxia. With the aging trend of society and the prolongation of life expectancy, the incidence of hypoxic-ischemic cerebrovascular disease has increased significantly, seriously endangering human health and bringing heavy burdens to society and families.

[0003] Cerebroprotein hydrolyzate ...

Examples

Embodiment 1

[0071] The preparation of embodiment 1NM dispersible tablet

[0072] 1. Prescription:

[0073] 6.5mg (calculated by amino nitrogen): 14.4mg (calculated by total nitrogen) specifications

[0074] Protein hydrolyzate 148.0g

[0075] Maleic acid 14.8g

[0076] Microcrystalline Cellulose 116.0g

[0077] Sodium starch glycolate 30.0g

[0078] 50% ethanol appropriate amount

[0079] Magnesium Stearate 3.0g

[0080] Micronized silica gel 3.0g

[0081]

[0082] A total of 1000 tablets were prepared

[0083] 13mg (calculated by amino nitrogen): 28.8mg (calculated by total nitrogen) specifications

[0084] Protein hydrolyzate 296.0g

[0085] Maleic acid 29.6g

[0086] Microcrystalline Cellulose 232.0g

[0087] Carboxymethyl starch sodium 60.0g

[0088] 50% ethanol appropriate amount

[0089] Magnesium Stearate 6.0g

[0090] Micronized silica gel 6.0g

[0091]

[0092] A total of 1000 tablets were prepared

[...